Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells

Hypertension

Volumn 30, Issue 5, 1997, Pages 1198-1203

  Shichiri, Masayoshi ^a   Kato, Hiroki ^b   Marumo, Fumiaki ^b   Hirata, Yukio ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Apoptosis; Cell survival; Endothelial cells; Endothelin 1; ET(B) receptor

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN;

ADOLESCENT; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ETIOLOGY; FLOW CYTOMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030667291     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1198     Document Type: Article

References (47)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetyleholine. Nature. 1980;288:373-376.
2. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function, FASEB J. 1992;6:2591-2599.
3. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev. 1990;70:427-451.
4. Gerritsen ME, Bloor CM, Endothelial cell gene expression in response to injury. FASEB J. 1993;7:523-532.
5. Schwartz SM, Gajdusek CM, Selden CS. Vascular wall growth control: the role of the endothelium. Atherosclerosis. 1981;1: 107-161.
6. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
7. Reidy MA. Endothelial regeneration, VIII: interaction of smooth muscle cells with endothelial regrowth. Lab Invest. 1988;59:36-43.
8. Cossmann D, Callow AD, Stein A, Matsumoto G. Early restcnosis after carotid endoarterectomy. Arch Surgery. 1978;113:275-278.
9. Unni KK, Kottke BA, Titus JL, Frye RL, Wallace RB, Brown AL. Pathologic changes after aortocoronary saphenous vein grafts. Am J Cardiol. 1974;34:526-532.
10. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
11. Hinchliffe JR, Thorogood PV. Genetic inhibition of mesenchymal cell death and the development of form and skeletal pattern in the limbs of talpid3 (ta3) mutant chick embryos. J Embryol Exp Morphol. 1974;31:747-760.
12. Antalikova L, Kren V, Bila V, Kasparek R, Rozinek J. Contribution to the morphometry of limb bud structures in the normodaetylous and polydactylous rat. I. Apical ectodermal ridge. Folia Morphol. 1990;38:402-407.
13. Williams L, Bell L. Asynchronous development of the rat colon. Anat Embryol. 1991;183:573-578.
14. Lewinson D, Silbermann M. Chondroclasts and endothelial cells collaborate in the process of cartilage resorption. Anat Rec. 1992; 233:504-514.
15. Furtwangler JA, Halt SH, Koskinen ML. Sutural morphogenesis in the mouse calvaria: the role of apoptosis. Acta Anat. 1985;124: 74-80.
16. Muta K, Krantz SB. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol. 1993;156:264-271.
17. Colotta F, Borre A, Wang JM, Tattanelli M, Maddalena F. Polentarutti N, Peri G, Mantovani A. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol. 1992;148:760-765.
18. Harrington EA, Bennett MR, Fanidi A, Evan GI. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 1994;13:3286-3295.
19. Koury MJ, Bonduranl MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science. 1990;248:378-381.
20. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human cosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood. 1991;78: 7542-2547.
21. Yonish RE, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 1991;352:345-347.
22. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol. 1991;138:447-453.
23. Araki S, Shimada Y, Kaji K, Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun. 1990;168:1194-1200.
24. Araki S, Simada Y, Kaji K, Hayashi H. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem Biophys Res Commun. 1990; 172:1081-1085.
25. Hamet P, Richard L, Dam TV, Teiger E, Orlov SN, Gaboury L, Gossard F, Tremblay J. Apoptosis in target organs of hypertension. Hypertension. 1995;26:642-648.
26. Bennett MR, Evan GI, Newby AC. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res. 1994;74:525-536.
27. Leszezynski D, Zhao Y, Luokkamaki M, Foegh ML. Apoptosis of vascular smooth muscle cells. Protein kinase C and onco-protein Bcl-2 are involved in regulalion of apoptosis in non- transformed rat vascular smooth muscle cells. Am J Pathol. 1994;145:1265-1270.
28. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-2259.
29. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415
30. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S, Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990;348:730-732.
31. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990;348: 732-735.
32. Yanagisawa M. The endothelin system: a new target for therapeutic intervention. Circulation. 1994;89:1320-1322.
33. Takuwa N, Takuwa Y, Yanagisawa M, Yamashita K, Masaki T. A novel vasoactive peptide endothelin stimulates ontogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem. 1989; 264:7856-7861.
34. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest. 1989;83:708-712.
35. Shichiri M, Hirata Y, Nakajima T, Ando K, Imai T, Yanagisawa M, Masaki T, Marumo F. Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. J Clin Invest. 1991;87: 1867-1871.
36. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T. Ohta K, Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest. 1993;91: 1367-1373.
37. B receptors. Am J Physiol. 1995;269: H686-H695.
38. Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, Yanagisawa M. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell. 1994;79:1277-1285.
39. Hosoda K, Hammer RE, Richardson JA, Baynash AG, Yanagisawa M. Targeted and natural (Piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell. 1995;79:1267-1276.
40. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N, Jishage K, Ouchi Y, Azuma S, Toyoda Y, Ishikawa T, Kumada M, Yazaki Y, Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 1994;368:703-710.
41. Emori T, Hirata Y, Imai T, Eguchi S, Kanno K, Marumo F. Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology. 1993;133:2474-2480.
42. Herrmann Ö, Lorenz HM, Voll R, Grunke M, Woith W, Kalden JR, A rapid and simple method for the isolation of apoptotie DNA fragments. Nucleic Acids Res. 1994;22:5506-5507.
43. Kato H, Shichiri M, Marumo F, Hirata Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology. 1997;138:2615-2620.
44. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F. Presence of immunoreactive endothelin in human plasma, FEBS Lett. 1989;245:164-166.
45. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inoue A, Marumo F, Plasma endothelin levels in hypertension and chronic renal failure. Hypertension. 1990;15:443-496.
46. Tsukada T, Eguchi K, Migita K, Kawabe Y, Kawakami A, Matsuoka N, Tukashimu H, Mizokami A, Nagataki S. Transforming growth factor β1 induces apoptotie cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem Biophys Res Commun. 1995;210:1076-1082.
47. Haimovitz FA, Balaban N, McLoughlin M, Ehleiter D, Michaeli J, Vlodavsky I, Fuks Z. Protein kinase C mediates basie fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 1994;54:2541-2597.